Crispr Therapeutics shares tumble after significant earnings miss
Investing.com - Paylocity Holdng (NASDAQ: PCTY) reported third quarter EPS of $1.61, $0.52 worse than the analyst estimate of $2.13. Revenue for the quarter came in at $454.55M versus the consensus estimate of $442M.
Guidance
Paylocity Holdng sees Q4 2025 revenue of $385.50M-$390.50M versus the analyst consensus of $381.80M.
Paylocity Holdng sees FY 2025 revenue of $1.58B-$1.59B versus the analyst consensus of $1.73B.
Paylocity Holdng’s stock price closed at $194.32. It is down -5.45% in the last 3 months and up 29.89% in the last 12 months.
Paylocity Holdng saw 8 positive EPS revisions and 6 negative EPS revisions in the last 90 days. See Paylocity Holdng’s stock price’s past reactions to earnings here.
According to InvestingPro, Paylocity Holdng’s Financial Health score is "good performance".
Check out Paylocity Holdng’s recent earnings performance, and Paylocity Holdng’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar